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• A neurological exam is mean to be performed in juvenile dogs with lethargy, raised temperature and showing no response to
conventional treatment.
• Less invasive diagnostic techniques are needed.
• SRMA has still many unknown aspects that require further research or improvements.
• The majority of animals overcome the disease despite some of them may relapse.
?
Steroid responsive meningitis-arteritis (SRMA) is an immune-mediated disease that causes inflammation of the meninges and
associated arteries in young dogs (6-18 months). It causes cervical hyperesthesia, pyrexia, neutrophilic pleocytosis and increased
protein concentration in the cerebrospinal fluid (CSF). Examination of CSF is the most important diagnostic tool. Any breed can develop
the disease; however, some breeds seem to be predisposed. The standard treatment is based on prednisone starting at 4 mg/kg/day
and gradually decreasing this dose until at least 6 months.
INTRODUCTION
• To determine which factors of SRMA are the most
recurrent in HCV.
• To compare the results to existing literature.
OBJECTIVES
CONCLUSIONS
Figure 3. Neutrophilic pleocytosis in
a dog with SRMA. Whitney MS and
Coates JR. Cerebrospinal Fluid
Analysis in the Dog and Cat. In:























Figure 1. Sex, breed and count of relapses in the studied cases, 21 in total. (A) Sex
of the animals. (B) Amount of relapses and male/female distribution in percentages.








Figure 2. Beagle exhibiting neck
pain due to inflammatory condition
SRMA. Platt S, Freeman AC.
“Neck and back pain”. In: BSAVA
Manual of Canine and Feline
Neurology. British Small Animal
Veterinary Association; 2013
Described prednisone monotherapy tipically lasts
between 5 and 14 months. First dose (4 mg/kg/d) is
administered intravenously. In the studied cases longer
treatments tan the standard have been generally found.
TREATMENT
Figure 4. Prednisone treatment dose and duration in weeks. Sample
size is 17 dogs. Error bars show the standard deviation of the average
values.
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